...رونين وثمانمئة ألف تسلسل في دلتا . وبحسب...
Transcript
00:00Ronin and 800,000 sequences in Delta. According to Business, Sabir identified thirty two mutations on a protein of variable shape.
00:08And it's a remarkable performer that looks like a crown on the surface of the virus
00:11It helps to invade cells, where scientists say other worrisome variables have fewer sudden mutations.
00:20Lady said scientists are still waiting for laboratory studies to determine the ability of the antibodies to the Corona virus
00:27whether from the natural enemy or vaccines on resistance or deception. They're also watching carefully to see how quickly the new variable spreads around the world.
00:37Particularly in countries with high vaccination rates.
00:42as fears of the new corona shift increase , the fastest - pacing drug companies around the world wonder
00:50In her search for new vaccines
00:53or the development of existing vaccines. In this context, the company of our American Director of Medicine announced
00:59She'll develop a booster shot against the virus
01:03New and McEnroe. The head of the company, Stefan Ban Sil, said that the variables in the transgenic micron are worrying
01:12Which pushed the company to move as quickly as possible
01:15to implement its strategy in order to confront the axis, according to him.
01:22For its part, the American Drug Company, Nova Scotia, has started working on the manufacture of an anti-mutilator vaccine
01:32About Byers Corona.
01:34The company has made it clear that the vaccine targeting the new strain of Koron may be ready
01:41for testing and manufacturing in the next few weeks.
01:45Earlier, the World Health Organization was transformed or micro-fueled as worrying, prompting a number of countries to
01:53to place urgent restrictions
01:55It's about travel.
01:59the new challenge confronts the pharmaceutical companies in a time of the street of corona
02:02it is a heavy shifter or a microbe to confront it. Our American manager company announced that it will develop a booster dose that is higher than the vaccine currently used.
02:12pointing out that this is one of three strategies
02:15She's working on it to counter the new threat. The American Pfizer company and its German partner Bayo Tech are waiting for more information about the new shifter,
02:24But they confirmed the possibility of intensifying a valuable vaccine
02:27within six weeks and start shipping the first batch through one hundred days. As for the British Company Astra Zenica, it announced that it is studying the impact of its vaccine
02:37On the new shapeshifter,
02:38and what it described as a cocktail of antibodies that were provided, adding that it hopes that its title will retain its effectiveness in front of the races. the interest while
02:47The American company Innu Fe said that it started testing its potential vaccine
02:51To assess the effectiveness against the new transgenic, it is expected that the test will take about two weeks. In a similar move, a company